Lenalidomide Maintenance Therapy for Multiple Myeloma

NCT01675141 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

NIH

Sponsor class

Stopped Original investigator left the NIH and the primary outcome was not reached

Conditions

Multiple Myeloma

Interventions

DRUG: Lenalidomide

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]